Mochi Health vs. Noom Med: prices, fine print, and the honest verdict

Tirzepatide pricing

Mochi Health: $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership. Noom Med does not offer tirzepatide.

Semaglutide pricing

On semaglutide, Mochi Health wins at $178 versus $199 all-in — $21/mo apart. Mochi Health: Semaglutide runs $178 a month all-in. Noom Med: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose.

Transparency

Mochi Health: Source-verified (verified 2026-08-05); names its pharmacy — company-owned compounding facility. Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Mochi Health: membership recurs monthly; cancel membership any time; recurs until cancelled; $79/mo membership recurs until cancelled. Noom Med: 12-week cycles; 12-week billing cycles.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: Mochi Health holds $278 on every rung (four-month titration: exactly $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

On semaglutide, Mochi Health prices at $178 against $199 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Mochi Health's ranked figure is $278 ($199 medication + $79 mandatory membership); Noom Med publishes no figure to normalize. 2 · Maintenance basis. Mochi Health is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Mochi Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Mochi Health: source-verified, read 2026-08-05; Noom Med: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Mochi Health names company-owned compounding facility; Noom Med names Tailor Made Compounding (named) — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Mochi Health: a mandatory $79/mo membership folded into our all-in figure; cancel membership any time; recurs until cancelled; commitment: membership recurs monthly. Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Mochi Health carries source-verified pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — company-owned compounding facility, owned facility. Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Mochi Health-to-Noom Med move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Mochi Health: shipping included; consultation video visits included in membership; video visit model. Noom Med: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Mochi Health if the semaglutide line is cheaper here; you want a price that survives titration; unlimited included clinician and dietitian visits matter more than the last $60. Pick Noom Med if you refuse membership fees on principle. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are IVIM Health at $278 (dose-scaled, $75 membership included); Found at $289 (flat, no membership); ShedRx at $289 (dose-scaled, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $2,052/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.